Approval · Notice of Compliance 23500 · 2020
IBUPROFEN: Notice of Compliance 23500
Issued April 23, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23500
- Date
- April 23, 2020
- Company
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies